Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 3/20 | 0.45 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.45 |
| ▸ | CNR2 | P34972 | 3/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28654162 | 0.91 | POLB (0.49) | HSD17B1HSD17B2CNR2CNR1PARP1 | |
| SCHEMBL9853340 | 0.88 | DHODH (0.45) | HSD17B1HSD17B2PARP1HPGDTDP1 | |
| SCHEMBL9188288 | 0.88 | HSD17B1 (0.44) | HSD17B1HSD17B2PARP1HPGDTDP1 | |
| SCHEMBL147931 | 0.84 | ACHE (0.52) | HSD17B1HSD17B2TDP1LMNACYP3A4 | |
| SCHEMBL29391727 | 0.84 | ACHE (0.52) | HSD17B1HSD17B2TDP1LMNACYP3A4 | |
| SCHEMBL8766625 | 0.82 | ACHE (0.50) | HSD17B1HSD17B2TDP1LMNACYP3A4 | |
| SCHEMBL134721 | 0.82 | ACHE (0.55) | HSD17B1HSD17B2TDP1LMNACYP3A4 | |
| SCHEMBL29692933 | 0.82 | ACHE (0.55) | HSD17B1HSD17B2TDP1LMNACYP3A4 | |
| SCHEMBL13351679 | 0.82 | HSD17B1 (0.39) | HSD17B1HSD17B2PARP1HPGDTDP1 | |
| SCHEMBL9189111 | 0.81 | TDP1 (0.50) | HPGDTDP1LMNACYP3A4NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11535640-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| US-20200207794-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| EP-3526227-B1 | BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-06-03 | — | — | EP | disclosed |
| EP-2627730-B1 | FORMULATIONS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-10636990-B2 | Organic electroluminescence device | MERCK PATENT GMBH (DE) | 2020-04-28 | — | — | US | disclosed |
| EP-2748878-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2020-04-01 | — | — | EP | disclosed |
| WO-2018069196-A1 | BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2018-04-19 | — | — | WO | disclosed |
| US-20170309855-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2017-10-26 | — | — | US | disclosed |
| US-20170309855-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2017-10-26 | — | — | US | disclosed |
| US-9735385-B2 | Organic electroluminescence device | MERCK PATENT GMBH (DE) | 2017-08-15 | — | — | US | disclosed |
| US-20120037896-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2012-02-16 | — | — | US | disclosed |
| US-20120037896-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2012-02-16 | — | — | US | disclosed |
| US-20110284831-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-11-24 | — | — | US | disclosed |
| US-20110284831-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-11-24 | — | — | US | disclosed |
| WO-2011141109-A1 | ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2011-11-17 | — | — | WO | disclosed |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| WO-2010102706-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2010-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, SLCO4C1, GJA1 | HSD17B1 2254/4885HSD17B2 2700/4885CNR2 4021/4885 |
| US-20200207794-A1 | METAL COMPLEXES | IMMT, MCU, SOD1 | HSD17B1 4096/4885HSD17B2 3486/4885CNR2 3677/4885 |
| US-11535640-B2 | Metal complexes | IMMT, MCU, SOD1 | HSD17B1 4096/4885HSD17B2 3486/4885CNR2 3677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.